Apr. 15 at 1:34 PM
$AXSM , we posted the FAQ yesterday, today let's talk about why the payout stands out 🧵
~
$0.46/share. That's the estimated payout for the Axsome Therapeutics
$7.75M settlement. It's one of the highest per-share figures in recent biotech settlements.
For context:
$AXSM → ~
$0.46/share
$SNAP → ~
$0.14/share
$HPQ → ~
$0.20/share
$GE → ~
$0.05/share
📌 What happened with AXS-07?
Axsome was developing a migraine drug and pitching it to investors as having a clear FDA approval path. However, it was later revealed that the company knew about regulatory risks it wasn't disclosing. When those risks surfaced, the stock dropped, and investors who bought between 5/10/2021–4/22/2022 were left with losses.
$7.75M settlement reached, and late claims are still being considered, subject to court approval.
If you held
$AXSM during that window, don't wait:
https://11th.com/cases/axsome-investor-settlement